32nd EORTC-PAMM Group Winter Meeting (PAMM 2011)

of the EORTC as a whole. PAMM merged with Preclinical Therapeutics Models Group (PTMG) in 2000 and with the Screening and Pharmacology Group (SPG) in 2003.The latter group continued as the Drug Discovery Committee within PAMM. The groups have always been involved in the development of anticancer agents, evolving from platinum analogs, anthracyclines, nitrosoureas, antifolates in the 1980’s ... Konferencja: 32nd EORTC-PAMM 2011 Group Winter Meeting, 2.02.2011 – 5.02.2011, Sopot, Organizator: Wydział hemiczny II Konferencja iągłe doskonalenie w praktyce, Gdańsk 17.03.2011 Organizatorzy: Katedra Inżynierii Zarządzania Operacyjnego na Wydziale Zarządzania i Ekonomii Politechniki Gdańskiej, Naukowe Koło Jakości i Produktywności) Konferencja Mieszkać w porcie – Ideały ... CiteScore: 12.6 ℹ CiteScore: 2019: 12.6 CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of ... 2011-04-01: Data zakończenia: 2011-04-02: Organizator: Wydział Architektury Politechniki Gdańskiej we współpracy z HCU Hafencity University Hamburg, Miastem Gdynia, Towarzystwem Urbanistów Polskich oraz Pomorską Okręgową Izbą Architektów PAMM is the principal pre-clinical group of the European Organisation for the Research and Treatment of Cancer (EORTC). It focuses on all aspects of anticancer drug action and development.

[index] [208] [1008] [10463] [4914] [9335] [14146] [8564] [4465] [2091] [14662]

#

test2